Related Experiment Video
Updated: Jul 15, 2025

Efficient Generation of Pancreas/Duodenum Homeobox Protein 1+ Posterior Foregut/Pancreatic Progenitors from hPSCs in Adhesion Cultures
Published on: March 27, 2019
Mechanism of Endogenous Peptide PDYBX1 and Precursor Protein YBX1 in Hirschsprung's Disease
Qiaochu Sun1, Zhengke Zhi1, Chenglong Wang1
1Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
Insights
A novel peptide, PDYBX1, derived from YBX1, is upregulated in Hirschsprung's disease (HSCR). PDYBX1 counteracts YBX1 downregulation, promoting enteric neural cell migration and proliferation, offering potential HSCR therapeutic strategies.
Area of Science:
- Molecular biology
- Developmental biology
- Gastroenterology
Background:
- Endogenous peptides regulate cellular processes, but their role in Hirschsprung's disease (HSCR) is unknown.
- HSCR is a congenital disorder characterized by the absence of enteric ganglia in the distal colon.
Purpose of the Study:
- To investigate the role of an endogenous peptide derived from YBX1 (PDYBX1) in the pathogenesis of HSCR.
- To elucidate the molecular mechanism by which PDYBX1 affects enteric neural cell function.
Main Methods:
- Analysis of YBX1 and PDYBX1 expression in HSCR patient tissues.
- Transwell and cytoskeleton staining assays to assess cell migration.
- Immunoprecipitation and immunofluorescence to identify protein interactions.
- Western blotting to evaluate the ERK1/2 signaling pathway.
Main Results:
- PDYBX1 expression was upregulated, while its precursor YBX1 was downregulated in aganglionic HSCR colonic tissue.
- Silencing YBX1 inhibited enteric neural cell migration, an effect partially reversed by PDYBX1 treatment.
- PDYBX1 binds to ERK2, counteracting YBX1 downregulation-induced ERK1/2 pathway inhibition and promoting cell migration and proliferation.
Conclusions:
- The endogenous peptide PDYBX1 may mitigate the negative effects of YBX1 downregulation on enteric neural cells in HSCR.
- PDYBX1 shows potential as a therapeutic agent for HSCR by supporting enteric nervous system development.
Abstract:
Endogenous peptides, bioactive agents with a small molecular weight and outstanding absorbability, regulate various cellular processes and diseases. However, their role in the occurrence of Hirschsprung's disease (HSCR) remains unclear. Here, we found that the expression of an endogenous peptide derived from YBX1 (termed PDYBX1 in this study) was upregulated in the aganglionic colonic tissue of HSCR patients, whereas its precursor protein YBX1 was downregulated. As shown by Transwell and cytoskeleton staining assays, silencing YBX1 inhibited the migration of enteric neural cells, and this effect was partially reversed after treatment with PDYBX1. Moreover, immunoprecipitation and immunofluorescence revealed that ERK2 bound to YBX1 and PDYBX1. Downregulation of YBX1 blocked the ERK1/2 pathway, but upregulation of PDYBX1 counteracted this effect by binding to ERK2, thereby promoting cell migration and proliferation. Taken together, the endogenous peptide PDYBX1 may partially alleviate the inhibition of the ERK1/2 pathway caused by the downregulation of its precursor protein YBX1 to antagonize the impairment of enteric neural cells. PDYBX1 may be exploited to design a novel potential therapeutic agent for HSCR.
More Related Videos
Related Concept Videos
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Lysosomal Hydrolases
Pleiotropy
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Export of Misfolded Proteins out of the ER
Hedgehog Signaling Pathway

